The unfortunate case of a man in The Netherlands who was infected with COVID-19 for more than a year and half is documented in a new report. At 613 days, it’s the longest COVID infection we know about so far. So long, in fact, that the virus had time to evolve into a new variant inside the man’s body.
The 72-year-old man had a complex health history. He’d previously received a stem cell transplant to treat a form of blood cancer, but had later been diagnosed with another cancer, diffuse large B cell lymphoma. As a result of the medication he was taking for that, he was severely immunocompromised, meaning a serious case of
He caught COVID in February 2022, and was treated with a combination of monoclonal antibodies and steroids. Unfortunately, the medicines didn’t work, and the infection became persistent. Although he had received several
For over 600 days, the patient remained infected with the virus, and had to be hospitalized several times. But it was very early on, just 21 days after his first treatment, that the signs of the virus
First, sequencing showed the virus had acquired a mutation known to be associated with resistance to sotrovimab, one of the drugs the man was treated with. Further analysis of 27 nasal swabs collected between February 2022 and September 2023 have now revealed over 50 different mutations, including some in the
In this man’s case, his underlying health issues meant his immune system never really stood a chance at clearing the virus. Long stays in hospital, coupled with the need to take extra precautions to avoid infecting others, took a toll on the man’s quality of life, but the medical team say there’s no evidence the highly mutated strain infected anyone else in the community.
In October 2023, the patient passed away as a result of a relapse of his underlying illness.
Although we’ve never seen one that has lasted quite this long, persistent infections are a recognized phenomenon with SARS-CoV-2. Some recent research suggested up to
The problem is, the longer a virus is replicating and evolving in the body, the more chance it has of picking up immune-escape mutations. That’s one theory for how the
“The duration of SARS-CoV-2 infection in this described case is extreme, but prolonged infections in immunocompromised patients are much more common compared to the general community,” the authors wrote in a
“Further work by our team includes describing a cohort of prolonged infections in immunocompromised patients from our hospital with infection durations varying between one month and two years. However, from the viewpoint of the general public, prolonged infections remain rare as the immunocompromised population is only a very small percentage of the total population.”
The case will be presented at the upcoming